Immunogenicity of C-terminus of Plasmodium falciparum merozoite surface protein 1 expressed as a non-glycosylated polypeptide in yeast

Acta Biochimica et Biophysica Sinica

Volumn 38, Issue 6, 2006, Pages 403-409

  Zhang, Zhong Guang ^a   Yu, Wen Gang ^a   Qiu, Wen Sheng ^a   Zhao, Heng Mei ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

C terminal region of merozoite surface protein 1 (MSP119); Immunity; Pichia pastoris; Plasmodium falciparum

Indexed keywords

IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; CULTURE MEDIUM; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION; IMMUNOLOGY; METABOLISM; MOUSE; PICHIA; PLASMODIUM FALCIPARUM; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CULTURE MEDIA; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOSYLATION; IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED C57BL; PICHIA; PLASMODIUM FALCIPARUM; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

PICHIA PASTORIS; PLASMODIUM FALCIPARUM;

EID: 33745142520     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2006.00178.x     Document Type: Article

References (30)

1. Sachs J Malaney P. The economic and social burden of malaria. Nature 2002, 415 : 680 685.
2. Singh S Kennedy MC Long CA Saul AJ Miller LH Stowers AW. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodiumfalciparum 42-kilodalton C-terminal merozoite surface protein 1. Infect Immun 2003, 71 : 6766 6774.
3. Kawabata Y Udono H Honma K Ueda M Mukae H Kadota J Kohno S et al. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii. Infect Immun 2002, 70 : 6075 6082.
4. Egan AF Blackman MJ Kaslow DC. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys. Infect Immun 2000, 68 : 1418 1427.
5. Blackman MJ Heidrich HG Donachie S McBride JS Holder AA. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 1990, 172 : 379 382.
6. Chang SP Gibson HL Lee-Ng CT Barr PJ Hui GS. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J Immunol 1992, 149 : 548 555.
7. Cereghino JL Cregg JM. Heterologous protein expression in the methyl-otrophic yeast Pichia pastoris. FEMS Microbiol Rev 2000, 24 : 45 66.
8. Bretthauer RK Castellino FJ. Glycosylation of Pichia pastoris-derived proteins. Biotechnol Appl Biochem 1999, 30 : 193 200.
9. Zhang ZG Zhao HM Gong YX. High-level expression and purification of C-terminal region of the merozoite surface protein 1 of Plasmodium falciparum in Pichia pastoris. Zhong Guo Ren Shou Gong Huang Bing Za Zhi 2005, 21 : 1047 1051.
10. MacRae AF Preiszner J Ng S Bolla RI. Expression of His-tagged Shigella IpaC in Arabidopsis. J Biotechnol 2004, 112 : 247 253.
11. Hoessli DC Poincelet M Gupta R Ilangumaran S Plasmodium falciparum merozoite surface protein 1. Eur J Biochem 2003, 270 : 366 375.
12. Romanos MA Scorer CA Clare JJ. Foreign gene expression in yeast: A review. Yeast 1992, 8 : 423 488.
13. Chen GH Tang SJ Chen CS Jiang ST. High-level production of recombinant chicken cystatin by Pichia pastoris and its application in mackerel surimi. J Agric Food Chem 2001, 49 : 641 646.
14. Brierley RA Bussineau C Kosson R Melton A Siegel RS. Fermentation development of recombinant Pichia pastoris expressing the heterologous gene: bovine lysozyme. Ann N Y Acad Sci 1990, 589 : 350 362.
15. Vedvick T Buckholz RG Engel M Urcan M Kinney J Provow S Siegel RS et al. High-level secretion of biologically active aprotinin from the yeast Pichia pastoris. J Ind Microbiol 1991, 7 : 197 201.
16. Minning S Serrano A Ferrer P Sola C Schmid RD Valero F. Optimization of the high-level production of Rhizopus oryzae lipase in Pichia pastoris. J Biotechnol 2001, 86 : 59 70.
17. Sreekrishna K Brankamp RG Kropp KE Blankenship DT Tsay JT Smith PL Wierschke JD et al. Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris. Gene 1997, 190 : 55 62.
18. Good MF Doolan DL. Immune effector mechanisms in malaria. Curr Opin Immunol 1999, 11 : 412 419.
19. Miller LH Good MF Kaslow DC. Vaccines against the blood stages of Falciparum malaria. Adv Exp Med Biol 1998, 452 : 193 205.
20. Hirunpetcharat C Tian JH Kaslow DC van Rooijen N Kumar S Berzofsky JA Miller LH et al. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Sac-charomyces cerevisiae: Correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J Immunol 1997, 159 : 3400 3411.
21. Kocken CH Withers-Martinez C Dubbeld MA van der Wel A Hackett F Valderrama A et al. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun 2002, 70 : 4471 4476.
22. Brady CP Shimp RL Miles AP Whitmore M Stowers AW. High-level production and purification of P30P2MSP1(19), an important vaccine antigen for malaria, expressed in the methylotropic yeast Pichia pastoris. Protein Expr Purif 2001, 23 : 468 475.
23. Pan W Huang D Zhang Q Qu L Zhang D Zhang X Xue X et al. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro. J Immunol 2004, 172 : 6167 6174.
24. Garraud O Mahanty S Perraut R. Malaria-specific antibody subclasses in immune individuals: A key source of information for vaccine design. Trends Immunol 2003, 24 : 30 35.
25. Shi YP Sayed U Qari SH Roberts JM Udhayakumar V Oloo AJ Hawley WA et al. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun 1996, 64 : 2716 2723.
26. Diallo TO Spiegel A Diouf A Lochouarn L Kaslow DC Tall A Perraut R et al. Short report: Differential evolution of immunoglobulin G1/G3 antibody responses to Plasmodium falciparum MSP 1(19) over time in malaria-immune adult Senegalese patients. Am J Trop Med Hyg 2002, 66 : 137 139.
27. Braga EM Barros RM Reis TA Fontes CJ Morais CG Martins MS et al. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region. Am J Trop Med Hyg 2002, 66 : 461 466.
28. Diallo TO Nguer CM Dieye A Spiegel A Perraut R Garraud O. Immune responses to P. falciparum-MSP1 antigen: Lack of correlation between antibody responses and the capacity of peripheral cellular immune effectors to respond to this antigen in vitro. Immunol Lett 1999, 67 : 217 221.
29. Hensmann M Li C Moss C Lindo V Greer F Watts C Ogun SA et al. Disulfide bonds in merozoite surface protein 1 of the malaria parasite impede efficient antigen processing and affect the in vivo antibody response. Eur J Immunol 2004, 34 : 639 648.
30. Cunha MG Rodrigues MM Soares IS. Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors. Vaccine 2001, 20 : 385 396.